Executive Series - Oventus Medical (OVN) Clinical Director & Co-Founder, Dr Chris Hart


Online Stockbroker

CommSec's Tom Piotrowski speaks with Oventus Medical (OVN) Clinical Director & Co-Founder, Dr Chris Hart about:

  • OVN’s Airway Technology and how it compares to Continuous Positive Airway Pressure (CPAP) devices which are commonly used to treat individual suffering from obstructive sleep apnoea and problem snoring.
  • OVN’s plans for the commercial rollout of its O2Vent product following FDA clearance,  which will see exclusive distribution in the US by OVN’s distribution partner Modern Dental – which covers approximately one quarter of US dentists through 34,000 dental offices.


Youtube Link:


To view more Executive Series interviews, visit:


1 stock mentioned

Online Stockbroker
Online Stockbroker

CommSec is Australia's leading online broker. CommSec has been committed to providing the best in online trading since 1995. CommSec helps make informed investment decisions with comprehensive market research, free live pricing and powerful...


No areas of expertise

I would like to

Only to be used for sending genuine email enquiries to the Contributor. Livewire Markets Pty Ltd reserves its right to take any legal or other appropriate action in relation to misuse of this service.

Personal Information Collection Statement
Your personal information will be passed to the Contributor and/or its authorised service provider to assist the Contributor to contact you about your investment enquiry. They are required not to use your information for any other purpose. Our privacy policy explains how we store personal information and how you may access, correct or complain about the handling of personal information.